Last reviewed · How we verify
NCT06028451
ManagemEnt of Antifungal Drug in Invasive Aspergillosis：a Real-word Study
trial testing Record the information data in Invasive Aspergillosis in 550 participants. Status unknown.
15 September 2024
Quick facts
| Lead sponsor | Southeast University, China |
|---|---|
| Status | Status unknown |
| Study type | OBSERVATIONAL |
| Enrollment | 550 |
| Start date | 25 September 2023 |
| Primary completion | 15 September 2024 |
| Estimated completion | 15 December 2024 |
| Sites | 1 location across China |
Drugs / interventions tested
- Record the information data
Conditions studied
- Invasive Aspergillosis — all drugs for Invasive Aspergillosis →
Sponsor
Southeast University, China
Who can join
18 and older, any sex, with Invasive Aspergillosis. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
To assessed the current situation and outcome of critically ill patients with invasive aspergillus infection.
Publications & conference data
No peer-reviewed publications indexed yet for this trial.
Verify or expand the search:
- PubMed search for NCT06028451
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Invasive Aspergillosis
Currently open trials in the same condition.
- NCT06583512 — Treatment Duration of IPA · active not recruiting
- NCT06382922 — Role of Antifungal Prophylaxis in Elderly Patients With Acute Myeloid Leukemia During Consolidation Therapy · recruiting
- NCT05101187 — Olorofim Aspergillus Infection Study · Phase 3 · active not recruiting
- NCT03717623 — Posaconazole Pharmacokinetics in Patients Receiving Chemotherapy or Stem Cell Transplants · Phase 4 · recruiting
- NCT06069505 — Detection of Azole Resistance Inducing Mutations on DNA Extracted Directly From Serum or Plasma of Immunocompromised Pat · recruiting
Other Southeast University, China trials
Trials by the same sponsor.
- NCT07519512 — Effect of Early Transition to Assisted Ventilation on 28-day Successful Extubation in Critically Ill Patients · NA · recruiting
- NCT06990477 — Effect of EIT-guided PEEP in ARDS Patients With Higher Recruitability · NA · recruiting
- NCT07362537 — Enteral Nutrition Delivery in Prone Position Ventilated Patients With Moderate to Severe ARDS · NA · recruiting
- NCT07327268 — Cyclic On-off Switching of Pulmonary Blood Flow in Moderate to Severe ARDS · not yet recruiting
- NCT07284888 — Practices of Prone Positioning Ventilation in Patients With Moderate-to-Severe ARDS in Intensive Care Units: A Registry- · recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT06028451 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Southeast University, China
- Last refreshed: 10 October 2023
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06028451.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing